about
A heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesisThe magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo.Dynamic NMR effects in breast cancer dynamic-contrast-enhanced MRIPre-operative systemic therapy in locally advanced breast cancer: a single institution experience.Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesisPeptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts.From bench to bedside: the growing use of translational research in cancer medicine.
P2860
Q28731921-8C5E239D-D4EB-44D8-9B15-D6A9D9BEB298Q33384078-E0B883D6-C970-405C-9558-C63AD09D031FQ33384373-BF0245B1-6CE2-4957-8C16-076E21E7555EQ35572926-C18A393E-374B-4107-B906-845C45DCFA15Q37265743-FA1E6110-A543-493C-875E-89FD255DC040Q37478620-9A016CB9-8E33-45F2-9465-CE18D5D6AF29Q37698244-AE34CAE7-C493-4919-BA5F-D4EFB5A244D8
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiangiogenic agents in breast cancer.
@en
Antiangiogenic agents in breast cancer.
@nl
type
label
Antiangiogenic agents in breast cancer.
@en
Antiangiogenic agents in breast cancer.
@nl
prefLabel
Antiangiogenic agents in breast cancer.
@en
Antiangiogenic agents in breast cancer.
@nl
P2860
P1433
P1476
Antiangiogenic agents in breast cancer.
@en
P2093
John T Salter
Kathy D Miller
P2860
P304
P356
10.1080/07357900701648516
P577
2007-10-01T00:00:00Z